Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESR2 | hg19_v2_chr14_-_64804814_64804842 | 0.86 | 4.7e-08 | Click! |
ESRRA | hg19_v2_chr11_+_64073022_64073056 | 0.25 | 2.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_10197463 | 9.16 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr10_-_49812997 | 8.18 |
ENST00000417912.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr4_-_681114 | 7.97 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr14_+_24630465 | 7.87 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr10_-_49860525 | 7.38 |
ENST00000435790.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr11_-_102668879 | 7.36 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr12_+_113416191 | 6.79 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr12_+_113344755 | 6.77 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr19_+_18284477 | 6.63 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr17_-_34207295 | 6.13 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr11_-_60719213 | 6.11 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr16_-_67969888 | 6.01 |
ENST00000574576.2
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr16_-_67970990 | 5.57 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr21_+_43639211 | 5.53 |
ENST00000450121.1
ENST00000398449.3 ENST00000361802.2 |
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr19_+_10196981 | 5.50 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr3_+_122399444 | 5.41 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr21_+_27011899 | 5.24 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
chr5_+_131409476 | 5.23 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr21_+_42792442 | 5.19 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr6_+_31554779 | 5.02 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr17_+_77030267 | 5.02 |
ENST00000581774.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr12_-_57522813 | 5.01 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr1_-_8000872 | 4.90 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
chr20_+_53092123 | 4.84 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr3_-_122283079 | 4.83 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_127441406 | 4.76 |
ENST00000487473.1
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
chr15_+_67458357 | 4.74 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr10_+_91092241 | 4.68 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr10_-_79789291 | 4.66 |
ENST00000372371.3
|
POLR3A
|
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa |
chr11_+_20044600 | 4.66 |
ENST00000311043.8
|
NAV2
|
neuron navigator 2 |
chr9_-_123676827 | 4.64 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr10_-_6019455 | 4.54 |
ENST00000530685.1
ENST00000397255.3 ENST00000379971.1 ENST00000528354.1 ENST00000397250.2 ENST00000429135.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr11_-_4414880 | 4.46 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr11_-_72496976 | 4.42 |
ENST00000539138.1
ENST00000542989.1 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
chr2_+_228678550 | 4.39 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr8_+_23430157 | 4.37 |
ENST00000399967.3
|
FP15737
|
FP15737 |
chr10_-_49732281 | 4.36 |
ENST00000374170.1
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr6_+_31554826 | 4.26 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr6_+_31916733 | 4.22 |
ENST00000483004.1
|
CFB
|
complement factor B |
chr1_+_169075554 | 4.18 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr6_-_160148356 | 4.17 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr5_-_150473127 | 4.15 |
ENST00000521001.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr6_+_31554962 | 4.10 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr1_+_165796753 | 4.04 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
chr10_-_6019552 | 4.03 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr12_+_121647962 | 4.02 |
ENST00000542067.1
|
P2RX4
|
purinergic receptor P2X, ligand-gated ion channel, 4 |
chr4_+_154622652 | 3.98 |
ENST00000260010.6
|
TLR2
|
toll-like receptor 2 |
chr3_+_122283064 | 3.96 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr4_-_76944621 | 3.94 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr1_-_111743285 | 3.94 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr15_+_67430339 | 3.93 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
chr1_-_153521714 | 3.93 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr1_-_153521597 | 3.92 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr17_+_41158742 | 3.92 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr10_+_81107271 | 3.86 |
ENST00000448165.1
|
PPIF
|
peptidylprolyl isomerase F |
chr7_-_105319536 | 3.84 |
ENST00000477775.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr6_+_29691198 | 3.78 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr2_+_127413704 | 3.72 |
ENST00000409836.3
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr3_-_122283424 | 3.67 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_58613323 | 3.61 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr1_-_205782304 | 3.61 |
ENST00000367137.3
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1 |
chr19_-_6690723 | 3.60 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr5_-_150466692 | 3.58 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr11_+_63974135 | 3.53 |
ENST00000544997.1
ENST00000345728.5 ENST00000279227.5 |
FERMT3
|
fermitin family member 3 |
chr15_+_67418047 | 3.48 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr6_+_31555045 | 3.44 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
chr3_-_127455200 | 3.43 |
ENST00000398101.3
|
MGLL
|
monoglyceride lipase |
chr15_+_89181974 | 3.42 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr10_+_60028818 | 3.42 |
ENST00000333926.5
|
CISD1
|
CDGSH iron sulfur domain 1 |
chr6_+_32812568 | 3.40 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr19_+_44081344 | 3.38 |
ENST00000599207.1
|
PINLYP
|
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
chr1_-_205290865 | 3.35 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr2_+_127413677 | 3.34 |
ENST00000356887.7
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr17_-_20370847 | 3.33 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr17_-_40264692 | 3.33 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr9_-_136344197 | 3.31 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr2_-_202562716 | 3.27 |
ENST00000428900.2
|
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr9_-_95896550 | 3.26 |
ENST00000375446.4
|
NINJ1
|
ninjurin 1 |
chr21_+_43933946 | 3.24 |
ENST00000352133.2
|
SLC37A1
|
solute carrier family 37 (glucose-6-phosphate transporter), member 1 |
chr8_-_63951730 | 3.20 |
ENST00000260118.6
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
chr2_-_7005785 | 3.18 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr12_+_56075330 | 3.18 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
chr12_+_52626898 | 3.17 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr22_+_21128167 | 3.16 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr10_-_121296045 | 3.16 |
ENST00000392865.1
|
RGS10
|
regulator of G-protein signaling 10 |
chr16_+_57653989 | 3.15 |
ENST00000567835.1
ENST00000569372.1 ENST00000563548.1 ENST00000562003.1 |
GPR56
|
G protein-coupled receptor 56 |
chr15_-_64338521 | 3.13 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr20_-_62203808 | 3.12 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr6_-_160147925 | 3.09 |
ENST00000535561.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr16_+_57653854 | 3.09 |
ENST00000568908.1
ENST00000568909.1 ENST00000566778.1 ENST00000561988.1 |
GPR56
|
G protein-coupled receptor 56 |
chr2_-_225907150 | 3.07 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
chr16_+_66638685 | 3.06 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr19_-_55660561 | 2.99 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr9_-_136344237 | 2.96 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr19_-_54872556 | 2.96 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr19_+_45394477 | 2.95 |
ENST00000252487.5
ENST00000405636.2 ENST00000592434.1 ENST00000426677.2 ENST00000589649.1 |
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast) |
chr1_-_184943610 | 2.92 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr10_+_81107216 | 2.92 |
ENST00000394579.3
ENST00000225174.3 |
PPIF
|
peptidylprolyl isomerase F |
chr22_+_30821732 | 2.91 |
ENST00000355143.4
|
MTFP1
|
mitochondrial fission process 1 |
chr6_+_4706368 | 2.91 |
ENST00000328908.5
|
CDYL
|
chromodomain protein, Y-like |
chr2_+_74757050 | 2.82 |
ENST00000352222.3
ENST00000437202.1 |
HTRA2
|
HtrA serine peptidase 2 |
chr21_+_43919710 | 2.82 |
ENST00000398341.3
|
SLC37A1
|
solute carrier family 37 (glucose-6-phosphate transporter), member 1 |
chr10_-_49813090 | 2.81 |
ENST00000249601.4
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr1_+_15479021 | 2.78 |
ENST00000428417.1
|
TMEM51
|
transmembrane protein 51 |
chr19_-_17958832 | 2.76 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
chr15_+_89182178 | 2.76 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr9_-_123691047 | 2.75 |
ENST00000373887.3
|
TRAF1
|
TNF receptor-associated factor 1 |
chr2_-_202562774 | 2.75 |
ENST00000396886.3
ENST00000409143.1 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr2_+_127413481 | 2.75 |
ENST00000259254.4
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr15_+_89182156 | 2.74 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr21_+_27011584 | 2.73 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr17_-_45928521 | 2.73 |
ENST00000536300.1
|
SP6
|
Sp6 transcription factor |
chr16_+_57406368 | 2.72 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr6_+_32821924 | 2.72 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr3_-_122283100 | 2.72 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr16_+_3115298 | 2.70 |
ENST00000325568.5
ENST00000534507.1 |
IL32
|
interleukin 32 |
chr4_+_100495864 | 2.69 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
chr2_+_219433588 | 2.68 |
ENST00000295701.5
|
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe) |
chr11_-_104905840 | 2.65 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr11_+_313503 | 2.64 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr1_+_15479054 | 2.61 |
ENST00000376014.3
ENST00000451326.2 |
TMEM51
|
transmembrane protein 51 |
chr1_-_209825674 | 2.57 |
ENST00000367030.3
ENST00000356082.4 |
LAMB3
|
laminin, beta 3 |
chr4_+_89299994 | 2.54 |
ENST00000264346.7
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr7_-_107880508 | 2.53 |
ENST00000425651.2
|
NRCAM
|
neuronal cell adhesion molecule |
chr14_-_55369525 | 2.52 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
chr6_-_36355513 | 2.52 |
ENST00000340181.4
ENST00000373737.4 |
ETV7
|
ets variant 7 |
chr6_-_11779174 | 2.52 |
ENST00000379413.2
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr19_+_676385 | 2.51 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
chr14_+_21525981 | 2.49 |
ENST00000308227.2
|
RNASE8
|
ribonuclease, RNase A family, 8 |
chr16_-_50715196 | 2.48 |
ENST00000423026.2
|
SNX20
|
sorting nexin 20 |
chr16_+_2039946 | 2.48 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr4_+_95972822 | 2.47 |
ENST00000509540.1
ENST00000440890.2 |
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr7_-_47621736 | 2.47 |
ENST00000311160.9
|
TNS3
|
tensin 3 |
chr3_+_10206545 | 2.46 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr11_+_20044096 | 2.45 |
ENST00000533917.1
|
NAV2
|
neuron navigator 2 |
chr18_-_53804580 | 2.45 |
ENST00000590484.1
ENST00000589293.1 ENST00000587904.1 ENST00000591974.1 |
RP11-456O19.4
|
RP11-456O19.4 |
chr12_-_89918522 | 2.44 |
ENST00000529983.2
|
GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
chr12_-_16759711 | 2.44 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr11_+_71709938 | 2.44 |
ENST00000393705.4
ENST00000337131.5 ENST00000531053.1 ENST00000404792.1 |
IL18BP
|
interleukin 18 binding protein |
chr19_-_10464570 | 2.44 |
ENST00000529739.1
|
TYK2
|
tyrosine kinase 2 |
chr6_-_138428613 | 2.43 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
chr3_-_127541194 | 2.43 |
ENST00000453507.2
|
MGLL
|
monoglyceride lipase |
chr12_+_102271129 | 2.42 |
ENST00000258534.8
|
DRAM1
|
DNA-damage regulated autophagy modulator 1 |
chr8_+_145149930 | 2.39 |
ENST00000318911.4
|
CYC1
|
cytochrome c-1 |
chr6_-_32820529 | 2.38 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr10_+_13142075 | 2.37 |
ENST00000378757.2
ENST00000430081.1 ENST00000378752.3 ENST00000378748.3 |
OPTN
|
optineurin |
chr1_+_28206150 | 2.36 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr22_-_47882857 | 2.36 |
ENST00000405369.3
|
LL22NC03-75H12.2
|
Novel protein; Uncharacterized protein |
chr7_-_38370536 | 2.36 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr2_-_89513402 | 2.35 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr7_+_128312346 | 2.34 |
ENST00000480462.1
ENST00000378704.3 ENST00000477515.1 |
FAM71F2
|
family with sequence similarity 71, member F2 |
chr19_-_10491234 | 2.34 |
ENST00000524462.1
ENST00000531836.1 ENST00000525621.1 |
TYK2
|
tyrosine kinase 2 |
chr16_+_3115378 | 2.32 |
ENST00000529550.1
ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32
|
interleukin 32 |
chr10_-_124713842 | 2.32 |
ENST00000481909.1
|
C10orf88
|
chromosome 10 open reading frame 88 |
chr17_+_25958174 | 2.31 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr1_-_212873267 | 2.30 |
ENST00000243440.1
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3 |
chr2_-_231090344 | 2.29 |
ENST00000540870.1
ENST00000416610.1 |
SP110
|
SP110 nuclear body protein |
chr11_+_71710648 | 2.27 |
ENST00000260049.5
|
IL18BP
|
interleukin 18 binding protein |
chr12_-_89919220 | 2.26 |
ENST00000549035.1
ENST00000393179.4 |
POC1B
|
POC1 centriolar protein B |
chr19_+_12949251 | 2.26 |
ENST00000251472.4
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr11_-_72385437 | 2.25 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr7_+_100728720 | 2.25 |
ENST00000306085.6
ENST00000412507.1 |
TRIM56
|
tripartite motif containing 56 |
chr6_-_31324943 | 2.24 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr17_+_6659153 | 2.24 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr20_+_58251716 | 2.24 |
ENST00000355648.4
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr1_+_28199047 | 2.23 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
chr6_-_31550192 | 2.23 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr6_+_31554612 | 2.22 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
chr18_+_55816546 | 2.20 |
ENST00000435432.2
ENST00000357895.5 ENST00000586263.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr6_+_32811885 | 2.19 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr19_+_4229495 | 2.19 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
chr7_-_92777606 | 2.17 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
chr17_+_40440481 | 2.16 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr10_+_6625605 | 2.16 |
ENST00000414894.1
ENST00000449648.1 |
PRKCQ-AS1
|
PRKCQ antisense RNA 1 |
chr4_-_7436671 | 2.14 |
ENST00000319098.4
|
PSAPL1
|
prosaposin-like 1 (gene/pseudogene) |
chr5_-_150460914 | 2.13 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr20_-_3996036 | 2.12 |
ENST00000336095.6
|
RNF24
|
ring finger protein 24 |
chr6_-_32821599 | 2.12 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr9_-_15307200 | 2.11 |
ENST00000506891.1
ENST00000541445.1 ENST00000512701.2 ENST00000380850.4 ENST00000297615.5 ENST00000355694.2 |
TTC39B
|
tetratricopeptide repeat domain 39B |
chr1_+_17866290 | 2.11 |
ENST00000361221.3
ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chrX_+_153455547 | 2.11 |
ENST00000430054.1
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive |
chr1_-_41328018 | 2.11 |
ENST00000372638.2
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr12_+_132413739 | 2.11 |
ENST00000443358.2
|
PUS1
|
pseudouridylate synthase 1 |
chr11_-_441964 | 2.10 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr16_+_3115323 | 2.10 |
ENST00000531965.1
ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32
|
interleukin 32 |
chr9_+_72658490 | 2.10 |
ENST00000377182.4
|
MAMDC2
|
MAM domain containing 2 |
chr16_+_56703737 | 2.10 |
ENST00000569155.1
|
MT1H
|
metallothionein 1H |
chr12_+_132413765 | 2.09 |
ENST00000376649.3
ENST00000322060.5 |
PUS1
|
pseudouridylate synthase 1 |
chr1_-_38218577 | 2.08 |
ENST00000540011.1
|
EPHA10
|
EPH receptor A10 |
chr17_+_77018896 | 2.07 |
ENST00000578229.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr21_+_45879814 | 2.07 |
ENST00000596691.1
|
LRRC3DN
|
LRRC3 downstream neighbor (non-protein coding) |
chr22_-_50964558 | 2.06 |
ENST00000535425.1
ENST00000439934.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
chr20_+_53092232 | 2.05 |
ENST00000395939.1
|
DOK5
|
docking protein 5 |
chr22_+_21996549 | 2.05 |
ENST00000248958.4
|
SDF2L1
|
stromal cell-derived factor 2-like 1 |
chr4_+_20255123 | 2.04 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr7_+_142636440 | 2.04 |
ENST00000458732.1
|
C7orf34
|
chromosome 7 open reading frame 34 |
chr7_-_131241361 | 2.03 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
chrX_+_150869023 | 2.02 |
ENST00000448324.1
|
PRRG3
|
proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) |
chr6_-_160114293 | 2.02 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr1_+_113217073 | 2.01 |
ENST00000369645.1
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 14.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
2.8 | 11.1 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
2.5 | 12.4 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
2.3 | 6.8 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
2.0 | 8.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 6.0 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
1.9 | 7.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.8 | 7.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.8 | 9.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.8 | 7.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
1.5 | 7.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.5 | 4.4 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.4 | 4.2 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
1.4 | 9.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.3 | 5.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.3 | 4.0 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
1.3 | 6.5 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
1.3 | 6.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.3 | 12.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.3 | 6.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.3 | 2.5 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
1.2 | 9.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.2 | 3.5 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.2 | 2.3 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.1 | 8.9 | GO:0018377 | protein myristoylation(GO:0018377) |
1.1 | 3.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
1.1 | 4.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.1 | 3.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.1 | 3.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.0 | 3.1 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
1.0 | 4.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.0 | 5.1 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
1.0 | 3.0 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.0 | 2.0 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.0 | 3.9 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
1.0 | 1.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.0 | 9.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
1.0 | 2.9 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.9 | 2.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.9 | 7.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 3.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.9 | 2.6 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.8 | 5.0 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.8 | 3.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.8 | 3.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.8 | 4.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.8 | 2.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.8 | 3.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.8 | 5.6 | GO:0033590 | response to cobalamin(GO:0033590) |
0.8 | 3.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.8 | 3.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.8 | 4.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 3.8 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.7 | 3.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.7 | 2.2 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.7 | 2.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.7 | 2.2 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
0.7 | 2.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.7 | 4.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.7 | 3.5 | GO:0060356 | leucine import(GO:0060356) |
0.7 | 7.7 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.7 | 7.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 2.1 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.7 | 3.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.7 | 2.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.7 | 2.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 3.3 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.7 | 4.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.0 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.7 | 6.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.7 | 10.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 2.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.6 | 3.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 0.6 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.6 | 3.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.9 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.6 | 4.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.6 | 1.8 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.6 | 3.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.6 | 4.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.6 | 1.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.6 | 1.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.6 | 1.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.6 | 2.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 4.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.5 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.5 | 15.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 3.1 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.5 | 5.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 3.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.5 | 3.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 3.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 4.4 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.5 | 2.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 1.5 | GO:1901189 | blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.5 | 1.4 | GO:1905026 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.5 | 1.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.5 | 1.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.5 | 1.9 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.5 | 3.3 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.5 | 1.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.5 | 0.5 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.5 | 0.9 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.5 | 8.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.5 | 1.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 1.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.4 | 3.5 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.4 | 2.2 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.4 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 2.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.4 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.4 | 1.3 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.4 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.4 | 1.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.4 | 5.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.4 | 1.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.4 | 5.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 2.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 0.9 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.4 | 1.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.4 | 1.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.4 | 1.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 2.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 2.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 5.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 2.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 1.2 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.4 | 1.2 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.4 | 1.2 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.4 | 3.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.4 | 1.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 0.8 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.4 | 5.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 1.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.4 | 1.2 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.4 | 1.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 8.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.8 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.4 | 2.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 4.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.4 | 1.5 | GO:1904647 | response to rotenone(GO:1904647) |
0.4 | 3.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 0.7 | GO:0009644 | response to high light intensity(GO:0009644) |
0.4 | 1.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 2.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 0.4 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.4 | 1.1 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.4 | 1.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 36.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 1.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.4 | 1.1 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.4 | 1.4 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.3 | 1.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 1.4 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.3 | 3.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.7 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.3 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 1.0 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 2.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.0 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.3 | 0.7 | GO:0070256 | regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.3 | 2.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 2.7 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.0 | GO:0032912 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.3 | 5.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.7 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.3 | 2.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 2.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.3 | 2.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 2.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 1.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.3 | 0.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 2.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.3 | 1.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.3 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 1.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.0 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 1.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.3 | 2.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 1.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 31.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 4.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 4.4 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 0.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.9 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
0.3 | 0.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 1.2 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.3 | 0.9 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.3 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.5 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.3 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 1.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 3.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.3 | 3.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 0.9 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.3 | 0.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.2 | GO:1904588 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.3 | 0.9 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.3 | 0.9 | GO:0061075 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.3 | 2.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 2.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 0.9 | GO:0003169 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.3 | 0.3 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.3 | 1.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.3 | 0.9 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.3 | 0.9 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.3 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 2.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 5.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.9 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.3 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 0.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 1.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.3 | 0.6 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.3 | 1.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.3 | 0.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.3 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 2.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.3 | 0.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 3.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.8 | GO:0035922 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
0.3 | 0.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.3 | 0.3 | GO:1903487 | regulation of lactation(GO:1903487) |
0.3 | 1.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 1.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 0.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.3 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 0.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 1.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.3 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 1.1 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.3 | 2.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.3 | 1.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.3 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
0.3 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 2.4 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.3 | 1.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 0.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.3 | 2.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.0 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.3 | 2.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.3 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.5 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.3 | 1.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) myoblast migration(GO:0051451) |
0.3 | 2.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 1.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 0.8 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 1.0 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.3 | 1.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 2.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 2.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 3.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 1.5 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.7 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.2 | 1.0 | GO:0071503 | response to heparin(GO:0071503) |
0.2 | 0.7 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.7 | GO:0071335 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.2 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 2.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.0 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 0.7 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 1.0 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 1.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 5.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0002859 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.2 | 1.0 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 4.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 2.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 3.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 1.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.5 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.2 | 3.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 1.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 0.7 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 1.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 2.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 2.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 2.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.7 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.2 | 1.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 1.1 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
0.2 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.9 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 2.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 1.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.4 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.2 | 1.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 2.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.2 | GO:0001694 | histamine metabolic process(GO:0001692) histamine biosynthetic process(GO:0001694) |
0.2 | 0.7 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.9 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.2 | 6.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.2 | GO:2000864 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) positive regulation of estrogen secretion(GO:2000863) regulation of estradiol secretion(GO:2000864) positive regulation of estradiol secretion(GO:2000866) |
0.2 | 0.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 1.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.2 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.2 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 1.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.4 | GO:0042704 | uterine wall breakdown(GO:0042704) |
0.2 | 1.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 4.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 0.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 0.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.5 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.2 | 6.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.2 | 0.6 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.2 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 3.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.8 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.2 | 2.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 2.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.6 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 0.4 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.2 | 0.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.2 | 1.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 0.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 1.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.4 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.2 | 0.6 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.2 | 2.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 1.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 1.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.2 | 1.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 11.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 2.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.8 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.6 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.2 | 0.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.2 | 0.6 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.2 | 0.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
0.2 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.6 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.6 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.6 | GO:0070541 | response to platinum ion(GO:0070541) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 1.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 0.5 | GO:0018201 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.2 | 0.5 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 2.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 2.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 1.4 | GO:0001554 | luteolysis(GO:0001554) |
0.2 | 0.7 | GO:0072302 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.2 | 1.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 3.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.2 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.2 | 1.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 2.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.7 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 3.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.9 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.0 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
0.2 | 0.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.2 | 0.9 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 1.0 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 1.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.5 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.2 | 0.3 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 1.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 3.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 2.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 1.8 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 0.8 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.2 | 0.7 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 7.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.2 | 0.3 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 13.3 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.2 | 0.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.2 | 0.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.3 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 0.5 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.2 | 0.3 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.2 | 1.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 10.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.6 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.2 | 1.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 5.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 1.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 1.4 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 4.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 2.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 1.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.2 | 1.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.5 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.2 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 2.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.2 | 0.5 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 0.6 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.2 | 0.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.1 | 0.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 5.4 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.3 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.7 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.6 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.3 | GO:0015827 | tryptophan transport(GO:0015827) |
0.1 | 1.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 2.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 3.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 1.2 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.1 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 3.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 2.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 1.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.1 | 0.7 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.5 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.9 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.5 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 2.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.8 | GO:1990441 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 1.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
0.1 | 0.9 | GO:0000423 | macromitophagy(GO:0000423) |
0.1 | 1.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 2.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.6 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0060700 | regulation of endoribonuclease activity(GO:0060699) regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.5 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.1 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.5 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.5 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 2.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 1.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 1.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 8.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 0.3 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 2.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.3 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.1 | 0.2 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.1 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 1.6 | GO:0009757 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 1.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 3.5 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.8 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 1.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.4 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.1 | 2.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.1 | 5.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.3 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 2.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 8.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.1 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.1 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 0.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 2.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 2.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 1.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.1 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) regulation of response to macrophage colony-stimulating factor(GO:1903969) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.1 | 1.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 4.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.1 | 2.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.1 | 1.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.1 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.1 | 2.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.1 | 0.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 2.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 2.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 0.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 0.9 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.3 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 1.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.8 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.1 | 1.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.2 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.3 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.5 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 6.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 1.3 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.3 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.1 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:0070189 | tryptophan catabolic process to kynurenine(GO:0019441) kynurenine metabolic process(GO:0070189) |
0.1 | 0.5 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 1.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 1.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 2.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.3 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 1.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.1 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.6 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 2.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 1.4 | GO:0072525 | NAD biosynthetic process(GO:0009435) pyridine-containing compound biosynthetic process(GO:0072525) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.1 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 4.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0046075 | dTTP metabolic process(GO:0046075) |
0.1 | 0.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.2 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.1 | 1.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.1 | 0.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.8 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.8 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.9 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.1 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.6 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.2 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 1.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 2.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.1 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.0 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 5.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.9 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0003097 | renal water transport(GO:0003097) |
0.1 | 0.3 | GO:1901374 | acetate ester transport(GO:1901374) |
0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.2 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.0 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.3 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 2.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.2 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 3.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.2 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
0.0 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.2 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.0 | 0.2 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.2 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.0 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:1990774 | tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.4 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 1.2 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.0 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.0 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 3.7 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.0 | 0.0 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.2 | GO:1904685 | maintenance of blood-brain barrier(GO:0035633) positive regulation of metalloendopeptidase activity(GO:1904685) |
0.0 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.6 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.1 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.0 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.3 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 1.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.0 | 0.1 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.6 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.0 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.0 | 0.2 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.1 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.0 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 1.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.5 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.0 | 3.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 22.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.7 | 14.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.4 | 4.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.9 | 9.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.9 | 2.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.8 | 5.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.8 | 18.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 5.6 | GO:0042825 | TAP complex(GO:0042825) |
0.7 | 2.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.7 | 3.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.6 | 1.9 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.6 | 1.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.6 | 6.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 3.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.5 | 3.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.5 | 3.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 4.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.5 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.5 | 1.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.5 | 6.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 1.4 | GO:0016938 | kinesin I complex(GO:0016938) |
0.5 | 5.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 2.4 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 4.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 0.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.4 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 1.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.4 | 1.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 3.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.3 | 8.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 1.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 1.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 3.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 1.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 1.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 0.9 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.3 | 0.9 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 1.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 3.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 1.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.3 | 0.9 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.3 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 3.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 2.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 1.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.3 | 1.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 2.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.3 | 6.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 2.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 5.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.2 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 2.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 1.5 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
0.2 | 6.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.7 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 0.9 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 3.5 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 5.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.2 | 0.6 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 3.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 2.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 1.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.2 | 0.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 1.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 6.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 3.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 5.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 10.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.3 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 0.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.5 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 16.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 3.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 2.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.5 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0034686 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.8 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 2.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 5.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 1.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 5.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 2.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 2.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 3.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 5.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.7 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 2.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 4.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 3.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 26.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 7.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 21.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 3.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 6.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 3.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 2.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.8 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 4.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 1.1 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.0 | 15.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.1 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.0 | 4.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 3.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.6 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0005816 | equatorial microtubule organizing center(GO:0000923) spindle pole body(GO:0005816) |
0.0 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.0 | 3.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.0 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.0 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.8 | 14.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
2.4 | 7.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.1 | 23.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
2.0 | 6.0 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
1.9 | 5.7 | GO:0042007 | interleukin-18 binding(GO:0042007) |
1.6 | 14.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.5 | 10.2 | GO:0046979 | TAP2 binding(GO:0046979) |
1.4 | 5.8 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.4 | 4.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.2 | 3.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.2 | 8.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.1 | 1.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
1.0 | 4.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.0 | 2.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.9 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.9 | 2.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.9 | 4.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.8 | 9.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 23.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.7 | 5.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 2.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.7 | 3.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.7 | 6.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 3.6 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 2.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
0.7 | 5.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 3.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 2.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.6 | 2.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 3.9 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 3.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 3.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.6 | 5.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.6 | 1.9 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 10.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 1.9 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.6 | 12.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.6 | 7.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 10.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 1.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.5 | 3.3 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.5 | 1.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.5 | 2.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.5 | 2.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 2.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 20.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 2.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.5 | 3.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 1.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 2.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.5 | 4.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 2.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.5 | 5.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 2.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 1.4 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.5 | 1.8 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.5 | 1.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.5 | 0.9 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.4 | 1.8 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 1.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.4 | 2.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 3.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.3 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.4 | 1.3 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.4 | 1.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.4 | 3.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.7 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.4 | 1.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 1.2 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.4 | 1.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.4 | 3.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 1.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 2.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.4 | 5.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 3.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 5.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 2.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 1.1 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.4 | 1.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.1 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.4 | 2.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.4 | 0.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.4 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 2.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.3 | 1.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.0 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.3 | 2.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 5.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 6.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 3.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 2.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.3 | 0.7 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 1.0 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.3 | 1.0 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.3 | 2.6 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.3 | 6.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 2.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 0.9 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.3 | 0.9 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.3 | 1.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 4.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.8 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.3 | 0.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.3 | 4.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 2.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 7.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 3.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 3.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 1.2 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.3 | 15.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 4.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 6.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 1.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 0.3 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.3 | 0.8 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.3 | 2.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 6.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 3.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.8 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.3 | 1.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 1.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 1.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 0.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.3 | 0.8 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 4.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.7 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 5.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.0 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.2 | 1.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 3.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 0.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 0.9 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.2 | 1.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 4.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.9 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.2 | 1.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 2.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.2 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 0.6 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 4.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 4.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 0.6 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.2 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.2 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.2 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 2.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 3.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 3.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 5.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 3.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 3.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 2.6 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 2.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 1.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.2 | 5.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.7 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.3 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.2 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 5.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.1 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 1.1 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 2.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 2.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 2.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 2.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 3.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 6.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 0.4 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 1.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 4.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 16.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.4 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 6.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.1 | 4.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.7 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.1 | 0.5 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 3.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 4.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 3.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 25.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.4 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) |
0.1 | 0.3 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 1.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 1.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 2.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 4.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 2.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 1.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 2.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.8 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 2.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 2.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 2.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 2.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.0 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 3.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 2.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 1.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 10.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 16.7 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 2.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0032396 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
0.1 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 4.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 10.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 2.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 23.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.6 | GO:0032041 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 1.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 9.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 4.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 4.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 3.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 2.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 2.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.0 | 0.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 2.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 1.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 1.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 1.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 1.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 9.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 1.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 3.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 20.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 24.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 1.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 9.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 3.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 4.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 8.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 1.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 12.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 15.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 18.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 5.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 4.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 5.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 5.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 9.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 4.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 5.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 6.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 5.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 6.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 6.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 7.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 9.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 4.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 4.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 15.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 20.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 3.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 0.8 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.7 | 58.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 17.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 5.6 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 32.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 8.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 6.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 10.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 6.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 3.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 0.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 0.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 0.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 8.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 17.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 18.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 10.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 7.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 6.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 7.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 11.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 11.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 4.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 11.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 13.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 3.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 6.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 6.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 6.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 3.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 4.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 4.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 4.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 6.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 5.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 3.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 2.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 4.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 7.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 9.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 10.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 5.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 5.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 8.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 1.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 2.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 4.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 1.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 8.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 3.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 21.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 2.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 5.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.7 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 7.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 2.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 4.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 9.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 4.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |